An implicit price of a DALY for use in a cost-benefit analysis of ARVs
Author
Abstract
Suggested Citation
DOI: 10.1080/00036840802600475
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
References listed on IDEAS
- Robert J. Brent, 2003. "Cost–Benefit Analysis and Health Care Evaluations," Books, Edward Elgar Publishing, number 2555.
Citations
Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
Cited by:
- Fernando Lavadenz & Carla Pantanali & Eliana Zeballos, 2015. "Thirty Years of the HIV/AIDS Epidemic in Argentina," World Bank Publications - Books, The World Bank Group, number 22124.
- Alberto Chong & Marco Gonzalez-Navarro & Dean Karlan & Martín Valdivia, 2020.
"Do Information Technologies Improve Teenagers’ Sexual Education? Evidence from a Randomized Evaluation in Colombia,"
The World Bank Economic Review, World Bank, vol. 34(2), pages 371-392.
- Alberto Chong & Marco Gonzalez-Navarro & Dean Karlan & Martin Valdivia, 2013. "Do Information Technologies Improve Teenagers’ Sexual Education? Evidence from a Randomized Evaluation in Colombia," NBER Working Papers 18776, National Bureau of Economic Research, Inc.
- Chong,Alberto & Gonzalez-Navarro,Marco & Karlan,Dean S. & Valdivia,Martin, 2019. "Do Information Technologies Improve Teenagers'Sexual Education ? Evidence from a Randomized Evaluation in Colombia," Policy Research Working Paper Series 8821, The World Bank.
- Chong, Alberto & Gonzalez-Navarro, Marco & Karlan, Dean & Valdivia, Martín, 2019. "Do Information Technologies Improve Teenagers’ Sexual Education? Evidence from a Randomized Evaluation in Colombia," Department of Agricultural & Resource Economics, UC Berkeley, Working Paper Series qt6th641vg, Department of Agricultural & Resource Economics, UC Berkeley.
- Stein, Alexander J., 2013. "Rethinking the measurement of undernutrition in a broader health context: Should we look at possible causes or actual effects:," IFPRI discussion papers 1298, International Food Policy Research Institute (IFPRI).
- N. Shamsi Gamchi & M. Esmaeili, 2023. "A novel mathematical model for prioritization of individuals to receive vaccine considering governmental health protocols," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 24(4), pages 633-646, June.
- Nafiseh Shamsi Gamchi & S. Ali Torabi & Fariborz Jolai, 2021. "A novel vehicle routing problem for vaccine distribution using SIR epidemic model," OR Spectrum: Quantitative Approaches in Management, Springer;Gesellschaft für Operations Research e.V., vol. 43(1), pages 155-188, March.
- Robert J. Brent, 2010. "Setting Priorities for HIV/AIDS Interventions," Books, Edward Elgar Publishing, number 12742.
- Robert J. Brent, 2012. "The Effects Of Hiv Medications On The Quality Of Life Of Older Adults In New York City," Health Economics, John Wiley & Sons, Ltd., vol. 21(8), pages 967-976, August.
- Robert J. Brent, 2023. "Cost-Benefit Analysis versus Cost-Effectiveness Analysis from a Societal Perspective in Healthcare," IJERPH, MDPI, vol. 20(5), pages 1-12, March.
- Brent, Robert J., 2016. "The value of reducing HIV stigma," Social Science & Medicine, Elsevier, vol. 151(C), pages 233-240.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Agata Kocia, 2020. "Governance Network in Polish Healthcare," Biomedical Journal of Scientific & Technical Research, Biomedical Research Network+, LLC, vol. 28(2), pages 21365-21371, June.
- Matin Qaim & Alexander J. Stein & J. V. Meenakshi, 2007.
"Economics of biofortification,"
Agricultural Economics, International Association of Agricultural Economists, vol. 37(s1), pages 119-133, December.
- Qaim, Matin & Stein, Alexander J. & Meenakshi, J.V., 2006. "Economics of Biofortification," 2006 Annual Meeting, August 12-18, 2006, Queensland, Australia 25584, International Association of Agricultural Economists.
- Robert Brent, 2009. "A cost-benefit analysis of a condom social marketing programme in Tanzania," Applied Economics, Taylor & Francis Journals, vol. 41(4), pages 497-509.
- Battistoni, Giuseppe & Genco, Mario & Marsilio, Marta & Pancotti, Chiara & Rossi, Sandro & Vignetti, Silvia, 2016. "Cost–benefit analysis of applied research infrastructure. Evidence from health care," Technological Forecasting and Social Change, Elsevier, vol. 112(C), pages 79-91.
- Mutambara, Jackqeline & Mwakiwa, Emmanuel & Mumaniki, Charity, 2013. "Effects of Agricultural Input Assistance on Households Affected by HIV/AIDS: A Case of Chirumanzu Communal Area," Asian Journal of Agriculture and Rural Development, Asian Economic and Social Society (AESS), vol. 3(07), pages 1-9, July.
- Robert J. Brent, 2010. "Setting Priorities for HIV/AIDS Interventions," Books, Edward Elgar Publishing, number 12742.
- Brent Robert J., 2013.
"A cost-benefit framework for evaluating conditional cash-transfer programs,"
Journal of Benefit-Cost Analysis, De Gruyter, vol. 4(2), pages 159-180, August.
- Brent, Robert J., 2013. "A cost-benefit framework for evaluating conditional cash-transfer programs," Journal of Benefit-Cost Analysis, Cambridge University Press, vol. 4(2), pages 159-180, August.
- John Creedy, 2008. "A note on discounting and the social time preference rate," Australian Journal of Labour Economics (AJLE), Bankwest Curtin Economics Centre (BCEC), Curtin Business School, vol. 11(3), pages 249-255.
- Lars Hultkrantz, 2021. "Discounting in economic evaluation of healthcare interventions: what about the risk term?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 22(3), pages 357-363, April.
- Robert Brent, 2009. "A cost-benefit analysis of female primary education as a means of reducing HIV/AIDS in Tanzania," Applied Economics, Taylor & Francis Journals, vol. 41(14), pages 1731-1743.
- James Buchanan & Sarah Wordsworth, 2015. "Welfarism Versus Extra-Welfarism: Can the Choice of Economic Evaluation Approach Impact on the Adoption Decisions Recommended by Economic Evaluation Studies?," PharmacoEconomics, Springer, vol. 33(6), pages 571-579, June.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:taf:applec:v:43:y:2011:i:11:p:1413-1421. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Chris Longhurst (email available below). General contact details of provider: http://www.tandfonline.com/RAEC20 .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.